Physician profile
Julia Pfaff
NPI 1952664609
$60,600.27
in general payments reported to CMS, 2019-2025
29 companies · $27K in 2025
The $27K reported for 2025 was more than what 98% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $185 · 2021: $1,195 · 2022: $2,861 · 2023: $23K · 2024: $5,747 · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $33K · Honoraria: $10K · Food and Beverage: $7,315 · Travel and Lodging: $5,675 · Gift: $3.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $33,250.00 |
| Honoraria | $10,000.00 |
| Food and Beverage | $7,315.11 |
| Travel and Lodging | $5,675.05 |
| Gift | $3.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $56,031.30 | 2021-2025 | Inspire |
| Ambu INC. | $1,403.29 | 2022-2023 | |
| Acclarent, INC | $578.58 | 2020-2024 | Acclarent Aera |
| Optinose US, INC. | $511.33 | 2019-2025 | |
| Intersect Ent, INC. | $397.49 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $330.85 | 2019-2025 | Dupixent |
| Integra Lifesciences Corporation | $233.08 | 2021-2024 | Inspira Air, Acclarent Aera, Trudi Probe |
| Aerin Medical INC. | $159.04 | 2022-2024 | |
| Genzyme Corporation | $128.58 | 2021-2023 | |
| Stryker Corporation | $117.26 | 2019-2024 | Fiagon Navigation Unit, Xpress Ent Dilation System |
| Medtronic, INC. | $72.67 | 2022-2025 | Propel |
| Hologic Sales and Service, LLC | $62.31 | 2024 | Coolseal Generator |
| Hikma Pharmaceuticals USA | $61.78 | 2023-2025 | Ryaltris |
| Surgenex LLC | $50.65 | 2025 | Surmatrix, Renograft, Pellograft |
| Glaxosmithkline, LLC. | $46.90 | 2023-2025 | Nucala |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $46.61 | 2020-2022 | |
| Phadia US INC. | $46.34 | 2021-2024 | Immunocap |
| Alk-Abello, INC | $42.31 | 2020-2021 | |
| Zoll Respicardia, INC. | $41.16 | 2024 | Remede System |
| C2dx, INC | $38.13 | 2023 | |
| Mimedx Group, INC. | $33.60 | 2025 | |
| Kerecis Limited | $29.65 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Microtransponder, INC. | $27.33 | 2023 | |
| Axogen | $22.40 | 2022 | |
| Bsn Medical INC | $21.57 | 2025 | |
| Merck Sharp & Dohme LLC | $18.23 | 2023 | |
| Ethicon US, LLC | $17.90 | 2019 | |
| Olympus America INC. | $17.05 | 2019 | |
| Acera Surgical, INC. | $12.88 | 2023 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Pfaff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.